Biomedical subjects
J Jervell
Publications and source records attributed to J Jervell.
[Insulin biosynthesis and degradation].
Explore the source record for details and available documents.
[Latent coronary insufficiency in juvenile diabetics].
Explore the source record for details and available documents.
Clinical use of a bio-assay of serum digitoxin activity.
Explore the source record for details and available documents.
Cardiovascular effects of glucagon.
Explore the source record for details and available documents.
In-vivo effects of the synalbumin insulin antagonist and of B-chain albumin.
Explore the source record for details and available documents.
Variations in synalbumin insulin antagonism during glucose-tolerance tests.
Explore the source record for details and available documents.
Inhibition of glutathione reductase in diabetics and non-diabetics.
Explore the source record for details and available documents.
Insulin antagonistic effect of human plasma albumin on protein synthesis in vitro and on glycogen synthesis in vivo in the rat diaphragm muscle.
Explore the source record for details and available documents.
Digitoxin kinetics in patients with impaired renal function.
Explore the source record for details and available documents.
Insulin-dependent diabetes, medical progress, and late complications.
Explore the source record for details and available documents.
A trial of a new adrenergic beta-receptor blocker, ICI 66.082, in the treatment of hypertension.
From a survey of 1250 males, 40-60 years of age, 25 mildly to moderately hypertensive patients have been offered treatment with the new beta-blocker ICI 66.082. Before and during the trial, data were obtained on resting BP and pulse rate, BP, pulse rate and ECGs during near maximal exercise, and various ventilatory function tests. In 15 patients, satisfactory BP control was obtained with ICI 66.082 alone, 25-100 mg twice daily. In 5 patients, the addition of hydralazine or a diuretic was necessary for satisfactory response. In 2 patients satisfactory control was not achieved and 3 patients were excluded for various reasons. Although BP and maximal pulse rate fell markedly during exercise, the total work capacity was not significantly reduced. No deleterious effect on ventilatory function was noted.
Prevalence of diabetes mellitus and impaired glucose tolerance in a rural Palestinian population.
The prevalence of diabetes mellitus and impaired glucose tolerance was investigated in a cross-sectional population-based study in a rural Palestinian population of 500 females and males aged 30-65 years. The prevalence of diabetes was 9.6% and 10.0% in females and males respectively. The prevalence of impaired glucose tolerance was 8.6%; 10.3% in females, 6.2% in males. The prevalence of total glucose intolerance (diabetes mellitus + impaired glucose tolerance) was 18.4%. Our study provides the first baseline data on diabetes mellitus and impaired glucose tolerance in Palestine. The results indicate a high prevalence of glucose intolerance, information that is essential for the implementation of national planning and service provision.
Diabetes mellitus in an urban Palestinian population: prevalence and associated factors.
We investigated the prevalence of diabetes and associated factors in a cross-sectional survey of an urban Palestinian population of 492 men and women aged 30-65 years. The oral glucose tolerance test was used to diagnose diabetes and impaired glucose tolerance. World Health Organization-recommended survey protocols were followed. Diabetes was found in 12.0% of the survey population (including 9.4% previously diagnosed), and impaired glucose tolerance in 5.9%. Logistic regression analysis controlling for age and sex revealed body mass index, waist-to-hip ratio and family history of diabetes to be significantly independently associated with diabetes.